Widely employed by GLP laboratories, safety assessment centers, leading universities, research institutions, and hospital respiratory departments in Singapore and globally.

Nose-only exposure systems serve as the primary method for acute inhalation exposure, ensuring precise dosage controls for toxicity assessments.

Inhalers are the preferred route of administration for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).

Beijing Huironghe Technology Co., Ltd. provides aerosol generation solutions for liquid and powder samples, facilitating precise simulation studies.

From SARS to COVID-19, specialized research fields such as pathogenic microorganism aerosol animal infection models are supported by our systems.
Singapore stands as a premier global hub for biomedical sciences, pharmaceutical research, and stringent healthcare technology validation. While the sale, possession, and use of e-cigarettes are strictly regulated under the Tobacco (Control of Advertisements and Sale) Act by the Health Sciences Authority (HSA), Singapore has simultaneously established itself as an essential R&D and testing powerhouse in the Asia-Pacific region. International manufacturers, contract research organizations (CROs), and academic laboratories leverage Singapore’s advanced infrastructure to conduct safety assessments, toxicological profiling, and aerosol characterization for global export markets.
The demand for high-quality e-cigarette testing equipment in Singapore is driven by the necessity to evaluate the biological effects of inhaled aerosols. As global regulations tighten, particularly with the FDA's PMTA (Premarket Tobacco Product Application) in the United States and the TPD (Tobacco Products Directive) in the European Union, exporters operating out of or collaborating with Singaporean research institutes must deploy highly precise, GLP-compliant testing instrumentation. These instruments simulate human inhalation patterns, generate controlled vapor profiles, and measure the deposition of fine particles within the respiratory tract.
Strict compliance standards set by the HSA and international bodies require e-cigarette testing systems to deliver reproducible aerosol generation, accurate aerodynamic particle size distribution (APSD), and precise chemical analysis of the aerosol constituents to ensure zero contamination and verified toxicity profiles.
In Singapore's bustling research clusters such as Biopolis and Tuas Biomedical Park, inhalation toxicology studies are critical not only for consumer product safety but also for drug delivery development. The technology used to test e-cigarettes shares a fundamental scientific foundation with therapeutic inhalers (like MDIs and DPIs) used for asthma and COPD treatments. Consequently, Singaporean research centers utilize nose-only exposure systems, cascade impactors, and breathing simulators to bridge the gap between therapeutic aerosol delivery and recreational aerosol toxicity testing.
Furthermore, local universities like the National University of Singapore (NUS) and Nanyang Technological University (NTU) continuously investigate the environmental impact of second-hand vapor and the long-term cellular effects of electronic nicotine delivery systems (ENDS). These academic endeavors require highly automated, multi-concentration exposure chambers that can handle rodents and other models with maximum biosafety and precise control parameters, ensuring that the generated data stands up to rigorous peer-review and regulatory scrutiny.
As we look toward the future of inhalation research, several trends are shaping the Singapore market:
Discover our core system designed for rodent respiratory research, highly integrated with Singapore's top academic toxicology studies:
Explore the Pulmonary Function Testing System for Rodents
Explore our comprehensive range of high-precision testing equipment designed to meet the rigorous demands of Singapore's scientific and regulatory sectors.

Streamlines sample preparation for pesticide residue and contaminant analysis in agricultural and e-liquid samples.

Delivers uniform aerosol concentration directly to the nasal passages of subjects, minimizing dermal absorption.

Allows simultaneous testing of multiple exposure concentrations to establish precise dose-response curves.

Specially designed interface for larger subject safety testing, complying with international GLP guidelines.

Engineered for advanced translational medicine studies, offering unparalleled exposure control and monitoring.

The industry standard for measuring the aerodynamic particle size distribution of inhalers and e-cigarette aerosols.

Accurately quantifies the fraction of fine particles delivered by nasal sprays and liquid droplet systems.

Simulates human physiological breathing patterns to test the delivery efficiency of nebulizers and vaporizers.
Navigating the complex landscape of inhalation toxicology requires more than just standard laboratory equipment. It demands a partnership with an exporter that understands the nuances of Singapore's scientific requirements and the international standards (such as OECD Guidelines for the Testing of Chemicals, specifically OECD 412 and 413 for subacute and subchronic inhalation toxicity).
Our instruments are designed with modularity and integration in mind. For example, our Multi-stage Cascade Impactor (NGI) provides critical data on the mass median aerodynamic diameter (MMAD) of e-cigarette vapor, which determines where particles deposit in the human respiratory tract—whether they reach the deep lungs (alveoli) or remain in the upper airways. When combined with our Breathing Simulator, researchers can replicate exact human usage profiles, generating highly realistic data that is vital for product safety submissions.
As the Singapore market continues to lead the region in biomedical innovation, having access to reliable, state-of-the-art inhalation testing technology is paramount. Beijing Huironghe Technology Co., Ltd. remains committed to exporting top-tier, high-performance instruments that empower scientists in Singapore and across the globe to conduct breakthrough research in inhalation safety, aerosol characterization, and respiratory health.